Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole vs Comparator in cSSSI
NCT00228982Phase 3Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Oct 2004
- Primary completion
- Dec 2005
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftobiprole medocaril in Skin and Skin Structure Infection (SSSI), sponsored by Basilea Pharmaceutica. Started Oct 2004; status: completed.
02
Drugs
ceftobiprole medocaril
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00228982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228982.